Red Bull Energy Drink Intake After Autologous Microsurgical Breast Reconstruction
NCT ID: NCT04397419
Last Updated: 2023-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2020-05-11
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prehabilitation on Fitness, Surgical Outcomes and Mitochondria Functionality in Patients With Esophageal Cancer
NCT04673968
The Effect of Deep Neuromuscular Block on the Perioperative Stress Response Reduction and Postoperative Recovery Enhancement in Robot-assisted Stomach Cancer Surgery
NCT03937440
Fast Track Recovery Surgery Among Gynecologic Oncology Patients
NCT03667755
Breast Cancer Diet Intervention Study
NCT03886389
Examining the Effectiveness of Carbohydrate Loading as a Nursing Intervention in Enhanced Recovery After Surgery
NCT06625996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The systolic and diastolic blood pressure as well as pulse will be measured non-invasively using a 24-hour ambulatory blood pressure monitor at regular intervals during the first postoperative 24 hours. Total fluid administered intraoperatively and postoperatively as well as intraoperative and postoperative administration of vasoactive drugs will be recorded. Daily urinary output will be measured during 24 hours after surgery. Pain levels will be measured on Numeric Rating Scale with values ranging from 0 to 10. Rate of operative re-explorations, flap loss and total length of primary hospital stay will be recorded. Wound healing and scarring will be assessed 1 month after surgery in our clinic and documented photographically.
The variables obtained from the intervention group receiving Red Bull® Energy Drink postoperatively will be compared with the corresponding variables of patients in the control group receiving the same amount of still water.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
This group is administered a total of 750 ml Red Bull® Energy Drink at defined time-intervals.
Red Bull Energy Drink
The intervention group receives 250 ml Red Bull Energy Drink 2-3 hours after surgery and 500 ml on postoperative day 1.
Regimen:
* 2-3 hours after surgery: 250 ml
* Postoperative day 1: morning and noon (1-1-0-0) 250 ml
Placebo group
This group is administered a total of 750 ml still water at defined time-intervals.
Still water
The control group receives 250 ml still water 2-3 hours after surgery and 500 ml on postoperative day 1.
Regimen:
* 2-3 hours after surgery: 250 ml
* Postoperative day 1: morning and noon (1-1-0-0) 250 ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Red Bull Energy Drink
The intervention group receives 250 ml Red Bull Energy Drink 2-3 hours after surgery and 500 ml on postoperative day 1.
Regimen:
* 2-3 hours after surgery: 250 ml
* Postoperative day 1: morning and noon (1-1-0-0) 250 ml
Still water
The control group receives 250 ml still water 2-3 hours after surgery and 500 ml on postoperative day 1.
Regimen:
* 2-3 hours after surgery: 250 ml
* Postoperative day 1: morning and noon (1-1-0-0) 250 ml
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Female participants ≥ 18 and ≤ 70 years of age
3. Able to give written informed consent prior to participation in the study, which includes ability to comply with the requirements and restrictions listed in the consent form.
Exclusion Criteria
2. History of cardiac rhythm disorder\*
3. History of Diabetes mellitus\*
4. History of gastric or duodenal ulcer\*
5. History of hyperthyroidism or hypothyroidism\*
6. Current use of antihypertensive drugs, antiarrhythmic drugs, thyroid hormones (e.g. Euthyrox)\*
7. Allergy or intolerance to component of Red Bull® Energy Drink
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Plastic Surgery Group AG by Prof. Jian Farhadi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. med. Nicole Speck
Prof. Dr. med. Jian Farhadi
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jian Farhadi, M.D., Prof.
Role: PRINCIPAL_INVESTIGATOR
University of Basel, Plastic Surgery Group AG by Prof. Jian Farhadi, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik Pyramide am See
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Speck NE, Michalak M, Dreier K, Babst D, Lardi AM, Farhadi J. Effect of the Red Bull Energy Drink on Perfusion-Related Variables in Women Undergoing Microsurgical Breast Reconstruction: Protocol and Analysis Plan for a Prospective, Multicenter Randomized Controlled Trial. JMIR Res Protoc. 2023 May 9;12:e38487. doi: 10.2196/38487.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-00493
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.